PMID: 12391288

Gruol DJ, King MN, Kuehne ME
Evidence for the locations of distinct steroid and Vinca alkaloid interaction domains within the murine mdr1b P-glycoprotein.
Mol Pharmacol. 2002 Nov;62(5):1238-48., [PubMed]
Sentences
No. Mutations Sentence Comment
117 ABCB1 p.Ala301Thr
X
ABCB1 p.Ala301Thr 12391288:117:53
status: NEW
view ABCB1 p.Ala301Thr details
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:117:63
status: NEW
view ABCB1 p.Ala301Val details
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:117:4
status: NEW
view ABCB1 p.Ala301Asp details
The A301D mutation occurs in the same residue as the A301T and A301V mutations. Login to comment
119 ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:119:42
status: NEW
view ABCB1 p.Ala229Val details
It contains two closely spaced mutations, A229V and W231L. Login to comment
127 ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:127:67
status: NEW
view ABCB1 p.Ala229Val details
In total, the process identified five new mutations, two of which (A229V, S308L) involve amino acids that had not been previously identified as contributing to steroid interactions with the P-gp. Login to comment
131 ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:131:331
status: NEW
view ABCB1 p.Ala301Asp details
ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:131:292
status: NEW
view ABCB1 p.Ala229Val details
The percentage of normalized change in resistance (N.C.R) is defined by the equation: N.C.R ϭ 100% ϫ (VAR IC50 - MS23IC50 )/(MS23 IC50 - W7TB IC50) Cell Line Vincristine Daunomycin Dexamethasone Puromycin Colchicine Mutation MSPD-10 N.C. ` ``` `` `` W231C MSPT-7 `` ``` ``` ``` ` A229V, W231L MSPD-60 `` N.C. ``` `` `` A301D MSMP-1 ` `` `` `` ``` S308L MSAC-52 ` N.C. `` N.C. ϩϩϩϩ L338F N.C., no change; ϩϩϩϩ, NCR increase Ն200%; `, NCR decrease Ն33%; ``, Ն67%; ```, Ն100%. Login to comment
153 ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:153:50
status: NEW
view ABCB1 p.Ala301Asp details
Daunomycin was used to evaluate the effect of the A301D mutation, expressed in the MSPD-60 cells, on the inhibitory activity of 5betaPodo. Login to comment
169 ABCB1 p.Trp232Cys
X
ABCB1 p.Trp232Cys 12391288:169:49
status: NEW
view ABCB1 p.Trp232Cys details
In the human protein, the comparable mutation is W232C. Login to comment
172 ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 12391288:172:19
status: NEW
view ABCB1 p.Leu339Cys details
However, the human L339C mutation produced a nearly complete loss of the ability of methanethiosulfonate-verapamil to induce ATPase activity. Login to comment
179 ABCB1 p.Ser228Thr
X
ABCB1 p.Ser228Thr 12391288:179:45
status: NEW
view ABCB1 p.Ser228Thr details
The most pronounced effect was caused by the S228T mutation expressed in the MSPP-21 cells. Login to comment
204 ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:204:44
status: NEW
view ABCB1 p.Ala301Val details
The mutation expressed in the MSPP-4 cells (A301V) shows the largest reduction of MEK-417 inhibitory activity. Login to comment
206 ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:206:34
status: NEW
view ABCB1 p.Ala301Val details
Thus, it seems unlikely that the (A301V) mutation interferes with the initial binding of Vinca alkaloids with the protein. Login to comment
207 ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:207:20
status: NEW
view ABCB1 p.Ala301Val details
It is possible that A301V promotes the transport of MEK-417 also, which would lead to lower inhibitory activity. Login to comment
298 ABCB1 p.Ala301Thr
X
ABCB1 p.Ala301Thr 12391288:298:63
status: NEW
view ABCB1 p.Ala301Thr details
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:298:56
status: NEW
view ABCB1 p.Ala301Val details
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:298:70
status: NEW
view ABCB1 p.Ala301Asp details
Multiple mutations were also found at the A301 residue (A301V, A301T, A301D), although much less frequently than the changes at W231. Login to comment